AstraZeneca met CEO Pascal Soriot ' s $40B revenue goal early. Now, it plans 15 drug launches by 2030

AstraZeneca has delivered on CEO Pascal Soriot’s promise to grow revenues to more than $40 billion by 2023. Now, the chief exec is already mapping out his next goal. | Pascal Soriot’s pledge to boost AstraZeneca’s revenue to more than $40 billion by 2023 has been met early, and the CEO is already…#astrazeneca #pascalsoriots #goal15

Source: Reuters: Health - February 9, 2023 Category: Consumer Health News Source Type: news